DENVER, CO — Patients at high risk of thromboembolism who require pacemaker or implantable cardioverter-defibrillator (ICD) surgery can safely remain onwarfarin, without interruption, rather than be ...

Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...

The common practice of administering heparin soon after cardioembolic stroke is associated with an increased risk for serious bleeding, according to an article in the Archives of Neurology. However, ...

Many patients receiving an ICD or a pacemaker are already receiving oral anticoagulants. Current guidelines recommend replacement of the oral anticoagulant with the temporary use of heparin as a ...

His home medications at admission included fluticasone 500 µg–salmeterol 50 µg dry powder inhaler (DPI) one inhalation every 12 hours, albuterol inhaler 180 µg (two puffs) every 4 hours as needed, ...

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared ...

Apixaban is a safe option for pediatric patients with a variety of congenital or acquired heart diseases who require chronic anticoagulation for thromboprophylaxis, the randomized SAXOPHONE study ...

Please provide your email address to receive an email when new articles are posted on . Venous thromboembolism causes substantial morbidity and mortality in patients with cancer. Patients with cancer ...

NEW YORK (Reuters) - A new crop of medicines to prevent stroke and blood clots could emerge within several years, easing dangers and hardships for patients and creating blockbuster sales for ...

Blood thinners are commonly used in the prevention of strokes. This is especially important for people who have suffered a first stroke, as they have an increased risk of suffering a second one. In ...

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared ...